Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/192742
Nanotechnological approaches to address photosensitizers' limitations: towards improved clinical applicability of photodynamic therapy
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Photodynamic therapy (PDT) uses a combination of molecular oxygen, light and a photosensitizer (PS) to generate singlet oxygen or reactive oxygen species (ROS), which can eradicate tumoral cells. All currently approved PSs for cancer treatment are molecular PSs. To date, no nanoparticlebased PSs are used clinically although it has widely been shown that nanotechnology may help to improve the properties of molecular PSs; for instance, molecular PSs suffer from some intrinsic limitations that undermine their therapeutic efficacy. In the present minireview, the most critical weaknesses exhibited by molecular PSs are described, and the potential use of nanoparticles (NPs) to address them and to reach the clinics is discussed.
Matèries
Matèries (anglès)
Citació
Citació
SPINELLI, Guglielmo, CABALLERO HERNÁNDEZ, Ana belén, GÁMEZ ENAMORADO, Patrick. Nanotechnological approaches to address photosensitizers' limitations: towards improved clinical applicability of photodynamic therapy. _Chemistry Squared_. 2022. Vol. 6, núm. 2. [consulta: 23 de gener de 2026]. ISSN: 2604-0794. [Disponible a: https://hdl.handle.net/2445/192742]